Effect of Probiotics in Non-alcoholic Fatty Liver Disease and Steatohepatitis

Summary

This study will evaluate the effect of probiotics, a beneficial intestinal bacteria supplement, if it will cause improvement of the non-alcoholic fatty liver disease (NAFLD) and or non-alcoholic steatohepatitis (NASH- an inflammation with concurrent fatty accumulation of the liver) as measured by transient elastography - an ultrasound of the liver that assess the elastic properties (density) and stiffness of the liver tissue. This study will enroll patients 18 years and older with diagnosis of NAFLD and or NASH.

Timeline

Start

2021-01-12

Primary completion

2022-03-01

Completion

2022-03-01

Outcome

Outcome not reported

Stopped (Enrollment): “lack of enrollment”

Drugs

Indications